160 related articles for article (PubMed ID: 7669445)
1. Importance of 1,25-dihydroxyvitamin D3 and the nonadherent cells of marrow for osteoblast differentiation from rat marrow stromal cells.
Rickard DJ; Kazhdan I; Leboy PS
Bone; 1995 Jun; 16(6):671-8. PubMed ID: 7669445
[TBL] [Abstract][Full Text] [Related]
2. Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2.
Rickard DJ; Sullivan TA; Shenker BJ; Leboy PS; Kazhdan I
Dev Biol; 1994 Jan; 161(1):218-28. PubMed ID: 8293874
[TBL] [Abstract][Full Text] [Related]
3. 1,25-dihydroxyvitamin D3 potentiates fluoride-stimulated collagen type I production in cultures of human bone marrow stromal osteoblast-like cells.
Kassem M; Mosekilde L; Eriksen EF
J Bone Miner Res; 1993 Dec; 8(12):1453-8. PubMed ID: 8304046
[TBL] [Abstract][Full Text] [Related]
4. Dexamethasone and retinoic acid differentially regulate growth and differentiation in an immortalised human clonal bone marrow stromal cell line with osteoblastic characteristics.
Ogston N; Harrison AJ; Cheung HF; Ashton BA; Hampson G
Steroids; 2002 Oct; 67(11):895-906. PubMed ID: 12234625
[TBL] [Abstract][Full Text] [Related]
5. Proliferation and differentiation of osteoblasts and adipocytes in rat bone marrow stromal cell cultures: effects of dexamethasone and calcitriol.
Atmani H; Chappard D; Basle MF
J Cell Biochem; 2003 May; 89(2):364-72. PubMed ID: 12704799
[TBL] [Abstract][Full Text] [Related]
6. Regulation of human bone marrow-derived osteoprogenitor cells by osteogenic growth factors.
Long MW; Robinson JA; Ashcraft EA; Mann KG
J Clin Invest; 1995 Feb; 95(2):881-7. PubMed ID: 7860771
[TBL] [Abstract][Full Text] [Related]
7. Dexamethasone induction of osteoblast mRNAs in rat marrow stromal cell cultures.
Leboy PS; Beresford JN; Devlin C; Owen ME
J Cell Physiol; 1991 Mar; 146(3):370-8. PubMed ID: 2022691
[TBL] [Abstract][Full Text] [Related]
8. The effects of dexamethasone and 1,25-dihydroxyvitamin D3 on osteogenic differentiation of human marrow stromal cells in vitro.
Beresford JN; Joyner CJ; Devlin C; Triffitt JT
Arch Oral Biol; 1994 Nov; 39(11):941-7. PubMed ID: 7695507
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of transforming growth factor beta2, dexamethasone and 1,25-dihydroxyvitamin D on human bone marrow stromal cells.
Fromigué O; Marie PJ; Lomri A
Cytokine; 1997 Aug; 9(8):613-23. PubMed ID: 9245490
[TBL] [Abstract][Full Text] [Related]
10. Regulation of BMP-induced transcription in cultured human bone marrow stromal cells.
Diefenderfer DL; Osyczka AM; Garino JP; Leboy PS
J Bone Joint Surg Am; 2003; 85-A Suppl 3():19-28. PubMed ID: 12925605
[TBL] [Abstract][Full Text] [Related]
11. Production and action of transforming growth factor-beta in human osteoblast cultures: dependence on cell differentiation and modulation by calcitriol.
Kassem M; Kveiborg M; Eriksen EF
Eur J Clin Invest; 2000 May; 30(5):429-37. PubMed ID: 10809903
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic effects of continuous or discontinuous treatment with dexamethasone and/or calcitriol on osteoblasts differentiated from rat bone marrow stromal cells.
Atmani H; Audrain C; Mercier L; Chappard D; Basle MF
J Cell Biochem; 2002; 85(3):640-50. PubMed ID: 11968004
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone.
Cheng SL; Yang JW; Rifas L; Zhang SF; Avioli LV
Endocrinology; 1994 Jan; 134(1):277-86. PubMed ID: 8275945
[TBL] [Abstract][Full Text] [Related]
14. Regulation of osteogenic differentiation of human bone marrow stromal cells: interaction between transforming growth factor-beta and 1,25(OH)(2) vitamin D(3) In vitro.
Liu P; Oyajobi BO; Russell RG; Scutt A
Calcif Tissue Int; 1999 Aug; 65(2):173-80. PubMed ID: 10430653
[TBL] [Abstract][Full Text] [Related]
15. Bone morphogenetic protein-2 and transforming growth factor-beta2 interact to modulate human bone marrow stromal cell proliferation and differentiation.
Fromigué O; Marie PJ; Lomri A
J Cell Biochem; 1998 Mar; 68(4):411-26. PubMed ID: 9493905
[TBL] [Abstract][Full Text] [Related]
16. Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts.
Jørgensen NR; Henriksen Z; Sørensen OH; Civitelli R
Steroids; 2004 Apr; 69(4):219-26. PubMed ID: 15183687
[TBL] [Abstract][Full Text] [Related]
17. Demineralized bone matrix mediates differentiation of bone marrow stromal cells in vitro: effect of age of cell donor.
Becerra J; Andrades JA; Ertl DC; Sorgente N; Nimni ME
J Bone Miner Res; 1996 Nov; 11(11):1703-14. PubMed ID: 8915778
[TBL] [Abstract][Full Text] [Related]
18. Effects of fluoride on human bone cells in vitro: differences in responsiveness between stromal osteoblast precursors and mature osteoblasts.
Kassem M; Mosekilde L; Eriksen EF
Eur J Endocrinol; 1994 Apr; 130(4):381-6. PubMed ID: 8162169
[TBL] [Abstract][Full Text] [Related]
19. Isolation and characterization of osteoblast precursor cells from human bone marrow.
Rickard DJ; Kassem M; Hefferan TE; Sarkar G; Spelsberg TC; Riggs BL
J Bone Miner Res; 1996 Mar; 11(3):312-24. PubMed ID: 8852942
[TBL] [Abstract][Full Text] [Related]
20. 1,25-dihydroxyvitamin D3-mediated transforming growth factor-beta release is impaired in cultured osteoblasts from patients with multiple pituitary hormone deficiencies.
Sterck JG; Klein-Nulend J; Burger EH; Lips P
J Bone Miner Res; 1996 Mar; 11(3):367-76. PubMed ID: 8852947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
